# PRDM7

## Overview
PRDM7 is a gene that encodes the PR/SET domain 7 protein, which is a member of the PRDM family known for its role in epigenetic regulation. The protein is characterized by the presence of a PR domain, homologous to the SET domain found in histone methyltransferases, and a variable number of zinc finger motifs, which are typically involved in DNA binding and protein-protein interactions (Woo2020Investigation; Di2021The). PRDM7 is primarily active in the nucleus and is implicated in chromatin modification, specifically through the methylation of histone H3 at lysine 4 (H3K4me), a modification associated with active chromatin and gene expression regulation (Di2021The). Despite its potential role in chromatin modification, PRDM7 has a mutation that affects its catalytic efficiency, suggesting a reduced or altered function compared to other PRDM family members (Di2021The). The gene has been implicated in cancer development, particularly in hepatocarcinoma, and is also studied for its expression in embryonic development, indicating a role in mesodermal differentiation and neural development (Woo2020Investigation; Casamassimi2020Multifaceted).

## Structure
PRDM7 is a protein characterized by the presence of a PR domain, which is homologous to the SET domain found in histone methyltransferases, and a variable number of zinc finger motifs. These zinc fingers are typically involved in DNA binding and protein-protein interactions (Woo2020Investigation; Di2021The). In humans, PRDM7 has undergone structural rearrangements, including an internal duplication of 89 bases in exon 10, leading to a frameshift and new splicing site, resulting in isoforms with varying zinc finger expression (Heerschop2021Pinpointing). 

The protein's zinc finger domain is disrupted by multiple mutations, which may affect its molecular structure and function (Ahlawat2016Zinc). In primates, PRDM7 mRNA is approximately 2000 nucleotides long, coding for a protein with KRAB and PR domains, and a C-terminal region of around 100 residues before a stop codon (Ahlawat2016Zinc). PRDM7 is noted for having rare splice variants that are deficient in C2H2 zinc fingers, suggesting that some variants may lack the zinc finger component (Di2021The). The protein may also undergo post-translational modifications such as phosphorylation, although specific details are not provided in the context.

## Function
PRDM7 is a member of the PRDM family of proteins, which are involved in epigenetic regulation through chromatin modification and transcriptional regulation. PRDM7 is characterized by its PR domain, which is homologous to the SET domain, suggesting potential histone methyltransferase activity. Specifically, PRDM7 is known to catalyze the methylation of histone H3 at lysine 4 (H3K4me), a modification associated with active chromatin and gene expression regulation (Di2021The). Despite its potential role in chromatin modification, PRDM7 has a mutation (Y357 to serine) that negatively impacts its catalytic efficiency compared to other PRDMs, such as PRDM9. Restoring this mutation to tyrosine can recover the catalytic levels observed in PRDM9, indicating that PRDM7 may have a reduced or altered function (Di2021The).

PRDM7 is primarily active in the nucleus, where it may influence processes like cell differentiation and development. However, the specific functions of PRDM7 in healthy human cells are not well-documented, and its precise role in cellular and organismal biology remains to be fully elucidated (Hohenauer2012The; Di2021The).

## Clinical Significance
The PRDM7 gene has been implicated in cancer development, particularly in hepatocarcinoma (LIHC). Overexpression of PRDM7 has been observed in hepatocarcinoma specimens, suggesting a potential role in cancer risk, especially in individuals with Li-Fraumeni-like syndrome who do not have TP53 mutations (Casamassimi2020Multifaceted). Although the specific mechanisms by which PRDM7 contributes to cancer are not fully understood, its overexpression may be associated with the development of certain cancers.

In the context of embryonic development, PRDM7 expression has been studied in mouse models, where it is primarily observed in craniofacial structures and somites, as well as in the developing brain and spinal cord. This expression pattern suggests a role in mesodermal differentiation and neural development (Woo2020Investigation). However, the clinical significance of PRDM7 overexpression in these contexts remains unclear, as the studies primarily focus on its expression patterns rather than direct clinical outcomes (Woo2020Investigation).

Overall, while PRDM7 is associated with certain cancer risks and developmental processes, further research is needed to elucidate its precise clinical implications and potential as a therapeutic target.

## Interactions



## References


[1. (Ahlawat2016Zinc) Sonika Ahlawat, Priyanka Sharma, Rekha Sharma, Reena Arora, and Sachinandan De. Zinc finger domain of the prdm9 gene on chromosome 1 exhibits high diversity in ruminants but its paralog prdm7 contains multiple disruptive mutations. PLOS ONE, 11(5):e0156159, May 2016. URL: http://dx.doi.org/10.1371/journal.pone.0156159, doi:10.1371/journal.pone.0156159. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0156159)

[2. (Heerschop2021Pinpointing) Sacha Heerschop, Zahra Fagrouch, Ernst J. Verschoor, and Hans Zischler. Pinpointing the prdm9-prdm7 gene duplication event during primate divergence. Frontiers in Genetics, February 2021. URL: http://dx.doi.org/10.3389/fgene.2021.593725, doi:10.3389/fgene.2021.593725. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2021.593725)

[3. (Casamassimi2020Multifaceted) Amelia Casamassimi, Monica Rienzo, Erika Di Zazzo, Anna Sorrentino, Donatella Fiore, Maria Chiara Proto, Bruno Moncharmont, Patrizia Gazzerro, Maurizio Bifulco, and Ciro Abbondanza. Multifaceted role of prdm proteins in human cancer. International Journal of Molecular Sciences, 21(7):2648, April 2020. URL: http://dx.doi.org/10.3390/ijms21072648, doi:10.3390/ijms21072648. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21072648)

[4. (Hohenauer2012The) Tobias Hohenauer and Adrian W. Moore. The prdm family: expanding roles in stem cells and development. Development, 139(13):2267–2282, July 2012. URL: http://dx.doi.org/10.1242/dev.070110, doi:10.1242/dev.070110. This article has 205 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.070110)

[5. (Woo2020Investigation) Jiwon Woo, Haewon Kang, Eunice Yoojin Lee, Sangkyu Park, and Yong Eun Cho. Investigation of prdm7 and prdm12 expression pattern during mouse embryonic development by using a modified passive clearing technique. Biochemical and Biophysical Research Communications, 524(2):346–353, April 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2019.12.133, doi:10.1016/j.bbrc.2019.12.133. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2019.12.133)

[6. (Di2021The) Federico Di Tullio, Megan Schwarz, Habiba Zorgati, Slim Mzoughi, and Ernesto Guccione. The duality of prdm proteins: epigenetic and structural perspectives. The FEBS Journal, 289(5):1256–1275, May 2021. URL: http://dx.doi.org/10.1111/febs.15844, doi:10.1111/febs.15844. This article has 35 citations.](https://doi.org/10.1111/febs.15844)